Images courtesy of Stentys
January 8, 2015 — Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients worldwide.
The Self-Apposing stent was first implanted during a “first-in-man” study in 2007. Since then, Stentys has enrolled more than 2,000 patients in clinical evaluations and conducted nine international clinical trials that have demonstrated the benefits of Self-Apposing technology over conventional options. The company has expanded marketing in Europe, the Middle East, Asia and South America, and is currently expecting approval of its Sirolimus-eluting stent in Europe before year end.
The Stentys Self-Apposing Stent solves the stent-sizing dilemma that cardiologists are confronted with when treating heart attack patients with conventional stents. The Stent’s flexible, self expanding design takes the shape of the patient’s unique vessel anatomy and is apposed to the irregular contours of a blood vessel, in particular after an AMI as the vessel dilates and the clot dissolves, thereby eliminating malapposition and the major complications seen with conventional stents.
For more information: www.stentys.com
April 17, 2024 
